IDPC presents key research on how the Committee on NGOs has effectively restricted civic space for drug NGOs wishing to engage in UN proceedings, and offers key recommendations for member states as they are preparing to elect new members of the Committee on NGOs in April 2022.

The Forum provided a space for UN, state and civil society representatives to consider how best to progress health, human rights and development in relation to drug policies.

IDPC releases a user-friendly resource for people from all sectors who wish to understand the key objectives, principles and concepts relating to decriminalisation of drug use and how to advocate for it.

Collaborating under the Support. Don't Punish campaign, IDPC & ARASA provide an overview of the key questions that drug decriminalisation advocates should consider to demand reform.

Dania Putri highlights and summarises the collective efforts of Support. Don't Punish campaigners worldwide to build a future without the war on drugs, where we can all thrive.

IDPC and GDPO take a critical look at the narratives that the UN drug control system constructs to justify its own existence, and to create an appearance of success.

IDPC and APCOF summarise discussions from a multi-stakeholder meeting addressing the links between criminalisation and human rights violations, regional policy developments and avenues for future reform.

IDPC highlights the many ways how people who use drugs are denied access to vital social protection services.

This report provides a comprehensive review of the human rights situation of people who use drugs in Nepal, and examines how Nepal’s repressive and outmoded drug policies are con­tributing to the violation of several human rights recognised under international and domestic law.

This PITCH paper highlights examples of positive shifts in policy, programme and service delivery as well as rights protections for people living with and at greatest risk of HIV, in response to the COVID-19 pandemic.

IDPC contextualises its most recent period of activities under the light of 15 lessons learnt over our network's fifteen years of existence.

The IDPC membership share insights on progress and setbacks in drug policy reform in 47 countries.

IDPC, TB/HIV Care and ARASA demonstrate how drug policy reform is a sustainable development issue that African countries need to urgently address to achieve the SDGs.

The Harm Reduction Consortium presents the first edition of the Global Drug Policy Index, which documents, measures and compares national-level drug policies against the UN Common Position on drugs.

This short document serves as a practical guide for civil society on possible ways to use the Model Drug Law in advancing drug policy reform in West Africa and beyond.

This ‘explainer’ aims to provide a more accessible summary of the key elements included in the West Africa Model Drug Law.

IDPC draws lessons from the challenges of tobacco control, including in relation to corporate capture, to inform the design of equitable, inclusive and sustainable cannabis legal regulation.

IDPC offers a historical analysis of civil society advocacy for drug policy reform at the UN, assessing gains, challenges and insight on how the latter have been generally overcome.

PRI and IDPC detail how policymakers and practitioners in the criminal legal system can reduce the imprisonment of women for drug-related offences in line with international standards.

The 64th session of the CND was marked by the increase in prominence of health and human rights narratives, the proceedings' 'hybrid format' and a welcome long-overdue shift in the US stance on harm reduction.